SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-113904
Filing Date
2020-10-09
Accepted
2020-10-09 16:05:16
Documents
5
Period of Report
2020-11-20
Effectiveness Date
2020-10-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2012966-5_def14a.htm DEF 14A 618672
2 GRAPHIC sg_scott-samuels.jpg GRAPHIC 6983
3 GRAPHIC tm2012966_ac-pager.jpg GRAPHIC 59373
4 GRAPHIC tm2012966d4-txt_beichibw.jpg GRAPHIC 41909
5 GRAPHIC tm2012966d5-lhd_anglobw.jpg GRAPHIC 441615
  Complete submission text file 0001104659-20-113904.txt   1308267
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37686 | Film No.: 201233244
SIC: 2834 Pharmaceutical Preparations